he morbidity, mortality, and cost, with most diabetes-related mortality due to macrovascular disease, specifically coronary artery and cerebrovascular disease.36 Treatment of hypertension and dyslipidemia in patients with diabetes decreases these complications and is cost-effective.37???43 The microvascular complications of diabetes, including neuropathy, nephropathy, and retinopathy and blindness